Next Article in Journal
Function of TREM1 and TREM2 in Liver-Related Diseases
Previous Article in Journal
Deciphering the Relevance of Bone ECM Signaling
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624

by
Anisha Viswanathan
1,2,
Aliyu Musa
3,
Akshaya Murugesan
1,2,4,
João R. Vale
5,6,
Carlos A. M. Afonso
6,
Saravanan Konda Mani
7,
Olli Yli-Harja
8,9,
Nuno R. Candeias
5,* and
Meenakshisundaram Kandhavelu
1,2,*
1
Molecular Signaling Lab, Faculty of Medicine and Health Technology, Tampere University and BioMeditech, P.O. Box 553, 33101 Tampere, Finland
2
Tays Cancer Center, Tampere University Hospital, 33520 Tampere, Finland
3
Predictive Medicine and Data Analytics Lab, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
4
Department of Biotechnology, Lady Doak College, Madurai 625002, India
5
Faculty of Engineering and Natural Sciences, Tampere University, 33101 Tampere, Finland
6
Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
7
Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
8
Computational Systems Biology Group, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
9
Institute for Systems Biology, 1441N 34th Street, Seattle, WA 98103-8904, USA
*
Authors to whom correspondence should be addressed.
Cells 2020, 9(12), 2631; https://doi.org/10.3390/cells9122631
Submission received: 23 November 2020 / Accepted: 24 November 2020 / Published: 7 December 2020
There is an error in the title of the paper [1]. The title of the article should be changed from “Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation)” to “Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect”.
In addition, the first affiliation “Molecular Signaling Lab, Faculty of Medicine and Health Technology, Tampere University, BioMeditech and Tays Cancer Center, Tampere University Hospital, P.O. Box 553, 33101 Tampere, Finland” should be split into two:
1 
Molecular Signaling Lab, Faculty of Medicine and Health Technology, Tampere University, BioMeditech and Tays Cancer Center, Tampere University Hospital, P.O. Box 553, 33101 Tampere, Finland
2 
Predictive Medicine and Data Analytics Lab, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
Thus, the original affiliation orders 2–8 should be changed to 3–9, respectively. The correct version is listed below:
Anisha Viswanathan 1,2, Aliyu Musa 3, Akshaya Murugesan 1,2,4, João R. Vale 5,6, Carlos A. M. Afonso 6, Saravanan Konda Mani 7, Olli Yli-Harja 8,9, Nuno R. Candeias 5,* and Meenakshisundaram Kandhavelu 1,2,*
1 
Molecular Signaling Lab, Faculty of Medicine and Health Technology, Tampere University and BioMeditech, P.O. Box 553, 33101 Tampere, Finland
2 
Tays Cancer Center, Tampere University Hospital, 33520 Tampere, Finland
3 
Predictive Medicine and Data Analytics Lab, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
4 
Department of Biotechnology, Lady Doak College, Madurai 625002, India
5 
Faculty of Engineering and Natural Sciences, Tampere University, 33101 Tampere, Finland
6 
Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
7 
Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
8 
Computational Systems Biology Group, Faculty of Medicine and Health Technology, Tampere University and BioMediTech, P.O. Box 553, 33101 Tampere, Finland
9 
Institute for Systems Biology, 1441N 34th Street, Seattle, WA 98103-8904, USA
We apologize for this error and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Viswanathan, A.; Musa, A.; Murugesan, A.; Vale, J.R.; Afonso, C.A.M.; Mani, S.K.; Yli-Harja, O.; Candeias, N.R.; Kandhavelu, M. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Viswanathan, A.; Musa, A.; Murugesan, A.; Vale, J.R.; Afonso, C.A.M.; Mani, S.K.; Yli-Harja, O.; Candeias, N.R.; Kandhavelu, M. Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624. Cells 2020, 9, 2631. https://doi.org/10.3390/cells9122631

AMA Style

Viswanathan A, Musa A, Murugesan A, Vale JR, Afonso CAM, Mani SK, Yli-Harja O, Candeias NR, Kandhavelu M. Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624. Cells. 2020; 9(12):2631. https://doi.org/10.3390/cells9122631

Chicago/Turabian Style

Viswanathan, Anisha, Aliyu Musa, Akshaya Murugesan, João R. Vale, Carlos A. M. Afonso, Saravanan Konda Mani, Olli Yli-Harja, Nuno R. Candeias, and Meenakshisundaram Kandhavelu. 2020. "Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624" Cells 9, no. 12: 2631. https://doi.org/10.3390/cells9122631

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop